pharmaceuticals

RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107

by

Unlocking the Future: RedHill’s New Patent Strengthens COVID-19 Therapeutics RedHill Biopharma’s recent patent achievement for its compound RHB-107 marks a critical advancement in the fight against COVID-19. Let’s delve into the implications of composition-of-matter coverage and explore future trends. The Power of Composition-of-Matter Coverage The novel patent strategy employed by RedHill extends beyond mere method-of-use … Read more

Study Indicates Lifestyle Choices are Correlated with Cardiovascular Disease Risk

by

Transforming Health: The Link Between Lifestyle and Cardiovascular Risk Recent findings from a study led by Mateusz Babicki, MD, PhD, have shed light on the profound impact of healthy lifestyle choices on cardiovascular disease (CVD) risk. This research, focusing on aspects such as diet, physical activity, and mental well-being, underscores the importance of lifestyle modifications … Read more

Scalp Symptoms Important in Identifying Cicatricial Alopecia Subtype

by

Understanding Cicatricial Alopecia: New Research Insights New research from the University of Pennsylvania highlights significant findings in cicatricial alopecia, a group of rare, chronic conditions leading to permanent hair loss. Lead investigator Noelle Desir, along with her research team, has uncovered scalp symptom associations that could improve diagnostic accuracy and treatment strategies. Scalp Symptoms as … Read more

New Diabetes Drug Takes Over As Old Treatments Fade

by

The Rising Star of Diabetes and Weight Management: Tirzepatide New research from Mass General Brigham indicates a transformative shift in diabetes and weight management treatments, with tirzepatide quickly overtaking traditional options like metformin and insulin. This growth reflects a dynamic change in prescribing patterns and a pivotal focus on obesity treatment. Tirzepatide, sold under the … Read more

Monocyte-to-HDL-C Ratio Correlated With Gout Risk and Renal Injury

by

The Rising Importance of Monocyte-to-HDL Ratio (MHR) in Predicting Gout Risk The latest research from Shanxi Bethune Hospital highlights a significant correlation between the monocyte-to-HDL cholesterol ratio (MHR) and gout risk. With gout affecting an increasing number of individuals globally, understanding this link could be pivotal in developing preventive strategies and therapies. What Makes MHR … Read more

New Protocol Accurately Diagnoses Pediatric Anesthetic Allergy

by

Unveiling the Future of Allergy Diagnosis: A Closer Look at Local Anesthetic Allergy Recent advancements in allergy diagnostics are rewriting the playbook on how we diagnose immediate-type local anesthetic allergies, particularly in children. A novel study has highlighted the efficacy of a two-tiered diagnostic approach, using intradermal tests followed by subcutaneous provocation. This method has … Read more

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025

by

The Future of Oncology: Bridging Rare Diseases and FDA Initiatives The landscape of oncology is rapidly evolving, especially with the convergence of rare disease treatments and the principles set by the FDA’s Project Optimus. This initiative seeks to optimize drug dosing, balancing efficacy and safety, which is key not only for cancer treatments but also … Read more

Trump signals new tariffs on tech and pharmaceuticals amid trade war

by

Trump’s New Phase in Trade Tariffs: A Closer Look As President Trump advances into the second week of his intensified trade war, the administration is signaling a shift in its strategy, targeting tech products and pharmaceuticals. This move marks a new phase of tariffs, with the potential to reshape global trade dynamics significantly. Temporary Exemptions … Read more

LB-102 Significantly Improves Disease Severity in Acute Schizophrenia, with John Kane, MD

by

LB-102: A New Horizon in Schizophrenia Treatment LB Pharmaceuticals has recently unveiled promising data from the NOVA phase 2 study at the 2025 Annual Congress of the Schizophrenia International Research Society. The study evaluated LB-102, a new benzamide antipsychotic, showing significant improvements in disease severity for patients with acute schizophrenia. With mean changes in Clinical … Read more

Douglas Pharmaceuticals installs AI-driven robots, faces up to tariff threat

by

The Future of Warehouse Automation in Pharmaceuticals As companies like Douglas Pharmaceuticals embrace advanced technology, the future of warehouse automation is looking increasingly automated and efficient. The integration of robotic systems, like the Kardex AutoStore, highlights a trend toward smarter, more responsive logistics in the pharmaceutical industry. Automating Efficiency: The Kardex AutoStore Advantage Douglas Pharmaceuticals … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]